Systems and methods for treating cardiac arrhythmias

• US 10,449,361 B2
• Filed: 01/08/2015
• Issued: 10/22/2019
• Est. Priority Date: 01/10/2014
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Stahmann, Jeffrey E., Simms, Jr., Howard D., Maile, Keith R., Kane, Michael J., Linder, William J.
• Primary Examiner(s): Layno, Carl H
• Assistant Examiner(s): Ghand, Jennifer L
• Application Number:
  US14/592,723
• Publication Number:
  US 20150196756A1
• Time in Patent Office: 1,748 Days
• CPC Class Codes: A61N 1/3621 for treating or preventing abnormally high heart rate
• CPC Class Codes: A61N 1/37288 Communication to several implantable medical devices within one patient
• CPC Class Codes: A61N 1/3756 Casings with electrodes thereon, e.g. leadless stimulators

Abstract

Systems and methods for coordinating treatment of abnormal heart activity using multiple implanted devices within a patient. In one example, abnormal heart activity may be sensed by a medical device system. One of the devices of the system may determine to deliver anti-tachycardia pacing therapy to the heart of the patient, and may communicate an instruction to another of the devices of the medical device system to deliver anti-tachycardia pacing (ATP) therapy to the heart. The receiving medical device may then deliver ATP therapy to the heart of the patient.

Claims

1. A method for delivering anti-tachycardia pacing therapy to a heart of a patient, the method comprising:

in a first one of a plurality of implantable medical devices, determining to deliver anti-tachycardia pacing therapy to the heart of the patient;

communicating a message from the first one of the plurality of implantable medical devices to a second one of the plurality of implantable medical devices, the message instructing the second one of the plurality of implantable medical devices to deliver anti-tachycardia pacing therapy to the heart, the message including one or more anti-tachycardia pacing therapy parameters provided by the first one of a plurality of implantable medical devices; and

in response to receiving the message that includes the one or more anti-tachycardia pacing parameters and the instruction to deliver anti-tachycardia pacing therapy to the heart, the second one of the plurality of implantable medical devices delivering a first one of a plurality of electrical stimulation pulses to the heart of the patient after a predefined amount of time following a QRS wave that is detected by the second one of the plurality of implantable medical devices after receiving the message, wherein the plurality of electrical stimulation pulses are based on the one or more anti-tachycardia pacing parameters that were included in the message.

2. The method of claim 1, wherein the message is a trigger for delivery of the plurality of electrical stimulation pulses.

3. The method of claim 1, wherein the first one of the plurality of implantable medical devices comprises a subcutaneous implantable cardioverter-defibrillator (SICD), and the second one of the plurality of implantable medical devices comprises a leadless pacemaker (LCP).

4. The method of claim 1, further comprising delivering anti-tachycardia pacing therapy in accordance with an anti-tachycardia pacing therapy protocol.

5. The method of claim 1, wherein the one or more anti-tachycardia pacing therapy parameters provided by the first one of the plurality of implantable medical devices include one or more of:

a pulse width of the plurality of electrical stimulation pulses;

an amplitude of the plurality of electrical stimulation pulses and a shape of the plurality of electrical stimulation pulses.

6. The method of claim 1, further comprising beginning to deliver the plurality of electrical stimulation pulses during a non-refractory period of the heart.

7. The method of claim 1, further comprising determining, by the second one of the plurality of implantable medical devices, a presence of an arrhythmia before delivering the plurality of electrical stimulation pulses.

8. The method of claim 1, wherein the second one of the plurality of implantable medical devices delivers the plurality of electrical stimulation pulses in synchrony with the rhythm of the heart of the patient.

9. The method of claim 1, wherein a communication link of the second one of the plurality of implantable medical devices is inactive until the second one of the plurality of implantable medical devices determines a presence of an arrhythmia or a predetermined heart rate.

10. The method of claim 1, wherein the communication by the first one of the plurality of implantable medical devices to the second one of the plurality of implantable medical devices is via conducted communication signals.

11. An implantable medical device system for delivering anti-tachycardia pacing therapy to a heart of a patient, the system comprising:

a first implantable medical device;

a second implantable medical device, wherein the first implantable medical device and the second implantable medical device are communicatively coupled;

wherein at least one of the first implantable medical device and the second implantable medical device is configured to deliver anti-tachycardia pacing therapy to the heart of the patient;

wherein the first implantable medical device is configured to determine to deliver anti-tachycardia pacing therapy to the heart of the patient;

wherein the first implantable medical device is configured to communicate multiple messages to the second implantable medical device to deliver anti-tachycardia pacing therapy to the heart of the patient; and

the second implantable medical device is configured to deliver one anti-tachycardia pacing pulse to the heart in response to receiving each of the multiple messages.

12. The system of claim 11, wherein the first implantable medical device is further configured to communicate one or more parameters of the anti-tachycardia pacing therapy to the second implantable medical device.

13. The system of claim 11, wherein the first implantable medical device comprises a subcutaneous implantable cardioverter-defibrillator (SICD), and the second implantable medical device comprises a leadless pacemaker (LCP).

14. A method for delivering anti-tachycardia pacing therapy to a heart of a patient, the method comprising:

in a first one of a plurality of implantable medical devices, determining to deliver anti-tachycardia pacing therapy to the heart of the patient;

communicating a message from the first one of the plurality of implantable medical devices to a second one of the plurality of implantable medical devices, the message instructing the second one of the plurality of implantable medical devices to deliver anti-tachycardia pacing therapy to the heart; and

in response to receiving the message, the second one of the plurality of implantable medical devices delivering anti-tachycardia pacing therapy to the heart of the patient, the second one of the plurality of implantable medical devices configured to begin delivering anti-tachycardia pacing therapy after a predefined amount of time following a QRS wave that is detected by the second one of the plurality of implantable medical devices after receiving the message to deliver anti-tachycardia pacing therapy.

15. The method of claim 14, wherein the second one of the plurality of implantable medical devices is configured to begin delivering anti-tachycardia pacing therapy during a non-refractory period of the heart.